• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMGEN/FLEXTRONICS INDUSTRIAL NEULASTA OBI; NEULASTA ON BODY INJECTOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMGEN/FLEXTRONICS INDUSTRIAL NEULASTA OBI; NEULASTA ON BODY INJECTOR Back to Search Results
Health Effect - Clinical Code No Patient Involvement (2645)
Date of Event 08/24/2017
Type of Reportable Event Malfunction
Event or Problem Description
Neulasta on body injector malfunctioned an hour prior to administration being due.Pt then brought in for neulasta injection.Dates of use: (b)(6)2017.Diagnosis or reason for use: neutropenia.Is the product compounded: no.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEULASTA OBI
Common Device Name
NEULASTA ON BODY INJECTOR
Manufacturer (Section D)
AMGEN/FLEXTRONICS INDUSTRIAL
MDR Report Key6830197
Report NumberMW5071821
Device Sequence Number16128506
Product Code KZH
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Nurse
Type of Report Initial
Report Date (Section B) 08/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date08/30/2017
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age78 YR
Patient Weight85
-
-